← Human Trials & Peer-Reviewed Studies
Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
Plain-language guide to PMID 12161519 (2002): randomized controlled trial of Human Growth Hormone in 18 subjects.
Key Facts
- PMID
- 12161519
- Journal
- The Journal of clinical endocrinology and metabolism
- Year
- 2002
- Study type
- Randomized Controlled Trial
- Authors
- Richmond E et al. (7 authors)
- DOI
- 10.1210/jcem.87.8.8770
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Human Growth Hormone.
A single injected pulse of GH inhibits the time-delayed secretion of GH in the adult by way of central mechanisms that drive somatostatin and repress GHRH outflow.
The marked amplification of spontaneous GH pulse amplitude in puberty poses an autoregulatory paradox.
Who Took Part
The study group was 18 subjects.
PubMed indexes the participants as children and teenagers, men only.
How the Study Was Run
The design is described as randomized.
The subjects were allocated by chance, so the Human Growth Hormone group and the comparison group should start out alike.
What Was Measured
The subject headings attached to it are Age Factors, Estradiol, Feedback, Physiological, Growth Hormone-Releasing Hormone, Homeostasis, Human Growth Hormone and Insulin-Like Growth Factor I.
What This Means in Plain Language
The paper is a randomized study of Human Growth Hormone in 18 subjects.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2002 (The Journal of clinical endocrinology and metabolism), a journal based in United States.
More context: the related Exogenous HGH, sermorelin & older GHRPs (why they're passed over) library page, all human trials.
Related Library Page
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.